Search Results 241-250 of 13892 for akathisia
ALEX Study: A Randomized, Phase III Study Comparing Alectinib with Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small ...
Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...
About this study. Evaluate the safety, tolerability, and efficacy of 28 days of treatment with ALLN-177 for reducing urinary oxalate excretion in patients ...
The purpose of this study is to compare rectal emptying and rectoanal pressures in healthy people and DD. Our hypotheses are that (i) the rate and amount of ...
About this study. The purpose of this study is to determine whether an EHT approach to DMT, defined as use of one of five monoclonal antibodies (alemtuzumab ...
The purpose of this study is to establish an aggregate database of information on the diagnosis, management (acute and definitive), surveillance and outcomes ...
This may precede clinically detectable disease, and could be used to predict disease onset, monitor response to treatment and predict prognosis. The purpose of ...
We will use a community-based participatory research (CBPR) approach with ANAI customer-owners, providers, and leaders to refine intervention materials and ...
About this study. The aim is the characterization of the microbiome of subjects experiencing benign reproductive tract disorders and its comparison to the ...
The purpose of this study is to characterize the immunophenotype of individuals with hypereosinophilia-associated cardiovascular, gastrointestinal, hematologic, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.